MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-HR-13-0005130
Farlex Pharmaceuticals Private Limited - pharma in Manimajra, Chandigarh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹15.67 Cr
▲ 25% YoY
Net profit · FY 2025
₹22.89 Lakh
Net margin 1.5%
EBITDA · FY 2025
₹55.38 Lakh
EBITDA margin 3.5%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Open charges
₹4.28 Cr
Secured borrowings
Company age
12 yrs
Est. 2014
Directors on board
2
As per MCA filings
About Farlex Pharmaceuticals Private Limited
Data last updated:
Farlex Pharmaceuticals Private Limited is a private limited company based in Manimajra, Chandigarh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 10 December 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U51397CH2014PTC035315. Its GSTIN is 06AACCF4946M1ZB (Haryana). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Saurabh Juneja and Aarti.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Scf 321 2nd Floor Motor Market, Manimajra, Chandigarh, India – 160101.
As per the financials filed for FY 2025, the company reported a revenue of ₹15.67 Cr, a growth of 25% compared to the previous year. For the same year it recorded a net profit of ₹22.89 Lakh (net margin 1.5%) and EBITDA of ₹55.38 Lakh (EBITDA margin 3.5%). Revenue has grown at a compounded annual rate (CAGR) of 11% over three years and 19% over five years.
The company is associated with 1 brand: Farlex Pharmaceuticals. As per MCA filings, the company has open charges of ₹4.28 Cr on record. Court records list 5 cases involving the company, including 5 filed by the company; 2 cases are pending.
Farlex Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-13-0005130). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website farlex.in.
Company details
CIN U51397CH2014PTC035315
Registration Number 035315
Incorporation Date 10 December 2014
ROC Chandigarh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-HR-13-0005130
Key People
Saurabh Juneja Director Aarti Director Recognitions & Rankings of Farlex Pharmaceuticals
Contact details
Farlex Pharmaceuticals Private Limited's registered office is in Manimajra, Chandigarh. Its website is farlex.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressScf 321 2nd Floor Motor Market, Manimajra, Chandigarh, India – 160101
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Farlex Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Farlex Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Farlex Pharmaceuticals operates one associated brand: Farlex Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical products are distributed and manufactured by Farlex Pharmaceuticals in India. | farlex.in |
Business activity
The main business activity of Farlex Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Farlex Pharmaceuticals Private Limited, buy the company report.
Financials of Farlex Pharmaceuticals Private Limited
FY 2024 filings availableFarlex Pharmaceuticals Private Limited reported revenue of ₹15.67 Cr (up 25% YoY) for FY 2025.
Revenue · FY 2025
₹15.67 Cr ▲ 25%
Net profit · FY 2025
₹22.89 Lakh margin 1.5%
EBITDA · FY 2025
₹55.38 Lakh margin 3.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 25%
3 years · compounded
▲ 11%
5 years · compounded
▲ 19%
EBITDA CAGR growth
1 year
▲ 22%
3 years · compounded
▲ 21%
5 years · compounded
▲ 25%
Revenue has grown at a compounded annual rate (CAGR) of 19% over five years, including 25% growth in the latest year. EBITDA rose 22% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹55.38 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹22.89 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.5% | ||||
| Net Profit Margin | 1.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Farlex Pharmaceuticals Private Limited, buy the company report.
Board of directors of Farlex Pharmaceuticals Private Limited
Farlex Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Saurabh Juneja Also directs: Kesar Aerosols Private Limited, Kesar Nutrition Private Limited, Farlex Lifesciences Private Limited and 2 more | Director | 09 Nov 2019 | 6 Years 11 Months | Current |
| Aarti Also directs: Farlex Lifesciences Private Limited | Director | 01 Mar 2017 | 9 Years 7 Months | Current |
Peer comparison
Farlex Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Vetecura Life Sciences Private Limited | ₹15.71 Cr (FY 2025) | 52.0% | Ulhasnagar, Maharashtra, India | |||
| Leeford Medicare Limited | ₹15.69 Cr (FY 2025) | 11.0% | Ludhiana, Punjab, India | |||
| Farlex Pharmaceuticals Private Limitedthis company | ₹15.67 Cr (FY 2025) | ₹22.89 Lakh | 1.5% | 25.0% | Manimajra, Chandigarh, India | |
| Medtech Pharma (India) Private Limited | ₹15.61 Cr (FY 2025) | 21.0% | New Delhi, Delhi, India |
To see the full peer comparison of Farlex Pharmaceuticals Private Limited, buy the company report.
Auditor
Farlex Pharmaceuticals Private Limited is audited by KBB & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KBB & CO. | FY 2023 | 023819N |
Shareholding
The shareholding of Farlex Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Farlex Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹4.28 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 01 May 2022 | 100565869 | Others | ₹3.99 Cr | Open | |
| 05 Oct 2018 | 100219269 | Hdfc Bank Limited | ₹29.31 Lakh | Open |
To see the full charge records of Farlex Pharmaceuticals Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
Farlex Pharmaceuticals Private Limited has 5 court cases on record: 5 filed by Farlex Pharmaceuticals. 2 cases are pending and 3 are disposed.
Total cases
5
Filed by the company
5
Pending
2
Disposed
3
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 5 | 0 | 2 |
Cases on record (4 of 5)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Panchkula, Haryana | Cheque dishonour complaint | Filed by the company against M/S Pelikas Healthcare Pvt Ltd and 1 other | Pending |
| District court, Panchkula, Haryana | Cheque dishonour complaint | Filed by the company against M/S Aushadhi Medical Agency and 1 other | Pending |
| District court, Chandigarh | Cheque dishonour complaint | Filed by the company against M/S Shanu Medical Agencies and 2 others | Disposed |
| District court, Panchkula, Haryana | Cheque dishonour complaint | Filed by the company against SLN Pharmaceuticals Distributors and 1 other | Disposed |
To see the full case history of Farlex Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Farlex Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Farlex Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AACCF4946M1ZB | Haryana | Active | 15 Jan 2019 |
To see the full GST registrations and return filing status of Farlex Pharmaceuticals Private Limited, buy the company report.
Recent activity
Farlex Pharmaceuticals Private Limited has 5 board changes on record since 2017: 2 appointments and 3 cessations. The latest: Inder Lal Juneja ceased to be Director on 18 Jun 2021.
Charges
A charge with Others of Rs. 399.00 Lakh registered on 01 May 2022 with Charge ID 100565869 was modified on 11 Sep 2025.
AGM
Farlex Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Farlex Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chandigarh.
Charges
A charge with Others amounted to Rs. 399.00 Lakh with Charge ID 100565869 was registered on 01 May 2022.
Ceased
Inder Lal Juneja ceased to be Director.
Charges
A charge with Hdfc Bank Limited of Rs. 29.31 Lakh registered on 05 Oct 2018 with Charge ID 100219269 was modified on 25 Jun 2020.
Appointed
Saurabh Juneja was appointed as Director.
Ceased
Saurabh Juneja ceased to be Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 29.31 Lakh with Charge ID 100219269 was registered on 05 Oct 2018.
Ceased
Harish Monga Kumar ceased to be Director.
Appointed
Aarti was appointed as Director.
Incorporation
10 Dec 2014
Farlex Pharmaceuticals Private Limited was registered on 10 Dec 2014 with Roc Chandigarh & aged 11 years 10 months as per MCA records.
Frequently asked questions
Farlex Pharmaceuticals is an active private limited company based in Manimajra, Chandigarh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 10 December 2014 (12+ years old) and is registered under CIN U51397CH2014PTC035315.
Farlex Pharmaceuticals has 2 current directors:
- Saurabh Juneja - Director
- Aarti - Director
The latest financial statements of Farlex Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Farlex Pharmaceuticals is 06AACCF4946M1ZB, registered in Haryana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Farlex Pharmaceuticals is U51397CH2014PTC035315. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Farlex Pharmaceuticals has 5 court cases on record: 5 filed by the company. 2 are pending.
Farlex Pharmaceuticals was incorporated on 10 December 2014, making it 12+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Farlex Pharmaceuticals by revenue are Vetecura Life Sciences Private Limited, Leeford Medicare Limited, Medtech Pharma (India) Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Inder Lal Juneja ceased to be Director on 18 Jun 2021. Saurabh Juneja was appointed as Director on 09 Nov 2019. Saurabh Juneja ceased to be Director on 11 May 2019. Farlex Pharmaceuticals has 5 board changes on record in total.
Yes, Farlex Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-HR-13-0005130).
Farlex Pharmaceuticals can be reached through the website farlex.in. Its registered office is in Manimajra, Chandigarh, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages